Results 241 to 250 of about 1,070,166 (331)

Fecal calprotectin in inflammatory bowel diseases: update and perspectives

open access: yesClinical Chemistry and Laboratory Medicine, 2017
H. Manceau   +3 more
semanticscholar   +1 more source

ETV1 Drives CD4+ T Cell‐Mediated Intestinal Inflammation in Inflammatory Bowel Disease Through Amino Acid Transporter Slc7a5

open access: yesAdvanced Science, EarlyView.
This study identifies the transcription factor ETV1 as a key driver of CD4⁺ T cell‐mediated intestinal inflammation in inflammatory bowel disease (IBD). ETV1 promotes CD4⁺ T cell activation, proliferation, and Th17 differentiation by activating the amino acid transporter SLC7A5, fueling metabolic reprogramming.
Yan Shi   +8 more
wiley   +1 more source

Hepatic manifestations of inflammatory bowel diseases

open access: yesLiver international (Print), 2017
S. Restellini   +2 more
semanticscholar   +1 more source

Burden of delirium on mortality and healthcare resource utilization in geriatric patients hospitalized for inflammatory bowel disease [PDF]

open access: green
Mohammad Aldiabat   +10 more
openalex   +1 more source

Notch2 Directs aTreg Cell Fate toward Immunoregulation or Inflammatory Pyroptosis

open access: yesAdvanced Science, EarlyView.
Schematic illustration showing that the Notch2 intracellular domain (NICD2) facilitates pyroptosis resistance in activated Tregs through the RREB1/Foxo1 signaling pathway. In addition, Notch2‐mediated pyroptosis resistance in activated Tregs promotes immunoregulatory capacity, thereby attenuating Th2‐driven inflammatory responses in allergic rhinitis ...
Yue‐Long Qiao   +10 more
wiley   +1 more source

Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease [PDF]

open access: gold
Peng Xiao   +16 more
openalex   +1 more source

Home - About - Disclaimer - Privacy